Yoshimasa T, Nakao K, Sakamoto M, Suda M, Morii N, Ikeda Y, Ishihara T, Manno M, Hamada S, Shimbo S
Acta Endocrinol (Copenh). 1984 Oct;107(2):261-7. doi: 10.1530/acta.0.1070261.
To elucidate whether or not human phaeochromocytoma contains methionine-enkephalin-Arg6-Gly7-Leu8 (Met-enkephalin-Arg-Gly-Leu) and methionine-enkephalin-Arg6-Phe7 (Met-enkephalin-Arg-Phe) together with methionine-enkephalin (Met-enkephalin) and leucine-enkephalin (Leu-enkephalin), all of which are known to exist in the same precursor molecule (preproenkephalin A), we examined extracts from 16 phaeochromocytomas using high performance liquid chromatography (HPLC) and gel exclusion chromatography coupled with radioimmunoassays (RIAs) for these four opioid peptides. Met-enkephalin-Arg-Gly-Leu-like immunoreactivity (-LI) and Met-enkephalin-Arg-Phe-LI existed together with Met-enkephalin-LI and Leu-enkephalin-LI in 16 phaeochromocytomas. There was a wide variation in contents of Met-enkephalin-LI, Leu-enkephalin-LI, Met-enkephalin-Arg-Gly-Leu-LI and Met-enkephalin-Arg-Phe-LI. Significant positive correlations were observed among the contents of these four opioid peptides in 16 phaeochromocytomas. HPLC and gel exclusion chromatography followed by the RIAs showed the presence of Met-enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Gly-Leu and Met-enkephalin-Arg-Phe together with their high molecular weight forms, which existed in variable amounts. Molar ratios of the contents of these four opioid peptides determined after HPLC varies from case to case. These results indicate the co-existence of Met-enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Gly-Leu and Met-enkephalin-Arg-Phe in human phaeochromocytomas, suggesting the preservation of amino acid sequences of these four opioid peptides even in neoplastic tissues.(ABSTRACT TRUNCATED AT 250 WORDS)
为了阐明人类嗜铬细胞瘤是否同时含有甲硫氨酸脑啡肽-Arg6-Gly7-Leu8(甲硫氨酸脑啡肽-Arg-Gly-Leu)、甲硫氨酸脑啡肽-Arg6-Phe7(甲硫氨酸脑啡肽-Arg-Phe)以及甲硫氨酸脑啡肽(甲硫氨酸脑啡肽)和亮氨酸脑啡肽(亮氨酸脑啡肽),已知所有这些都存在于同一前体分子(前脑啡肽原A)中,我们使用高效液相色谱(HPLC)和凝胶排阻色谱结合针对这四种阿片肽的放射免疫分析(RIA),检测了16个嗜铬细胞瘤的提取物。在16个嗜铬细胞瘤中,甲硫氨酸脑啡肽-Arg-Gly-Leu样免疫反应性(-LI)和甲硫氨酸脑啡肽-Arg-Phe-LI与甲硫氨酸脑啡肽-LI和亮氨酸脑啡肽-LI同时存在。甲硫氨酸脑啡肽-LI、亮氨酸脑啡肽-LI、甲硫氨酸脑啡肽-Arg-Gly-Leu-LI和甲硫氨酸脑啡肽-Arg-Phe-LI的含量存在很大差异。在16个嗜铬细胞瘤中,观察到这四种阿片肽的含量之间存在显著的正相关。HPLC和凝胶排阻色谱随后的RIA显示存在甲硫氨酸脑啡肽、亮氨酸脑啡肽、甲硫氨酸脑啡肽-Arg-Gly-Leu和甲硫氨酸脑啡肽-Arg-Phe及其高分子量形式,它们的含量各不相同。HPLC后测定的这四种阿片肽含量的摩尔比因病例而异。这些结果表明甲硫氨酸脑啡肽、亮氨酸脑啡肽、甲硫氨酸脑啡肽-Arg-Gly-Leu和甲硫氨酸脑啡肽-Arg-Phe在人类嗜铬细胞瘤中共存,提示即使在肿瘤组织中这四种阿片肽的氨基酸序列也得以保留。(摘要截短至250字)